Brookdale Shares Down 4.9% Despite Q1 Earnings Meeting Estimates

Brookdale Senior Living's (BKD) shares fell 4.9% after Q1 2025 results showed a net loss of $65 million, wider than the previous year's $29.6 million, driven by rising facility operating expenses and interest expenses, despite revenue increasing 4% to $813.9 million due to improved resident fees and occupancy; however, the company raised its full-year RevPAR and adjusted EBITDA guidance, now expecting RevPAR growth of 5%-5.75% and adjusted EBITDA between $440-$450 million.

Analysis

Brookdale Senior Living (BKD) experienced a 4.9% decline in its share price following the release of its first-quarter 2025 results, which presented a mixed financial picture. While total revenues and other operating income increased by 4% year-over-year to $813.9 million, slightly missing the Zacks Consensus Estimate by 0.8%, this growth was driven by a 4.5% rise in resident fees to $777.5 million, a 3% improvement in Revenue Per Occupied Unit (RevPOR), and a 140 basis point increase in weighted average occupancy to 79.3%. Consequently, Revenue Per Available Unit (RevPAR) grew 4.9% year-over-year. Despite these top-line gains and a narrowed loss per share of 11 cents, which was in line with estimates and better than the prior-year quarter's 13 cents loss, BKD's net loss widened significantly to $65 million from $29.6 million in the year-ago quarter. This deterioration was primarily due to a 2.7% increase in facility operating expenses to $557 million, driven by higher wage rates and utility costs, a 4.7% rise in general and administrative costs to $47.9 million, increased interest expenses, and costs associated with the extinguishment of a financing obligation. Positively, adjusted EBITDA grew 27.2% year-over-year to $124.1 million, and the company generated $23.4 million in net cash from operations, a notable improvement from a $1.1 million use of cash in the prior year, with adjusted free cash inflow reaching $3.8 million. However, Brookdale's balance sheet showed a decline in cash and cash equivalents to $239.7 million and a drop in total equity to $148.1 million, while long-term debt increased to $4.2 billion. Looking ahead, management provided an uplifted 2025 outlook, now projecting RevPAR growth of 5%-5.75% (up from 4.75%-5.75%) and adjusted EBITDA between $440-$450 million (up from $430-$445 million), with an expectation to deliver positive adjusted free cash flow of $30-$50 million.

Key Decisions for Investors

• Investors should carefully weigh Brookdale's improved operational performance and upgraded full-year guidance against the significant increase in net loss and the pressures on its balance sheet, such as increased debt and reduced cash reserves.
• Monitor the company's ability to effectively manage and control rising facility operating expenses and general and administrative costs, as these are currently key factors eroding profitability despite revenue growth.
• Assess the credibility of the company's path to achieving its 2025 adjusted free cash flow target of $30-$50 million, as sustained positive free cash flow will be critical for debt management and enhancing shareholder value amidst the current financial headwinds.